Published in Am J Clin Oncol on June 01, 1999
Chemotherapy as a component of multimodal therapy for gastric carcinoma. World J Gastroenterol (2006) 0.87
The interaction between N-WASP and the Arp2/3 complex links Cdc42-dependent signals to actin assembly. Cell (1999) 8.07
Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Proc Natl Acad Sci U S A (1980) 6.31
TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell (2001) 4.60
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours. Ann Oncol (2005) 3.53
The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells. Rev Med Virol (2000) 2.71
Infectiousness of Mycobacterium tuberculosis in HIV-1-infected patients with tuberculosis: a prospective study. Lancet (2000) 2.67
A two-site monoclonal antibody ELISA for the quantification of the major Dermatophagoides spp. allergens, Der p I and Der f I. J Immunol Methods (1989) 2.56
Whole-brain and regional brain atrophy in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol (2007) 2.51
Numbers of Giardia in the feces of infected children. Am J Trop Med Hyg (1975) 2.38
The human PRR2 gene, related to the human poliovirus receptor gene (PVR), is the true homolog of the murine MPH gene. Gene (1995) 2.19
Cdc42 is required for PIP(2)-induced actin polymerization and early development but not for cell viability. Curr Biol (2000) 2.19
Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med (1994) 2.14
Nectin4/PRR4, a new afadin-associated member of the nectin family that trans-interacts with nectin1/PRR1 through V domain interaction. J Biol Chem (2001) 2.09
Studies of electroimmunodiffusion: immunochemical quantitation of proteins in dilute solutions. Immunochemistry (1969) 2.05
Expansion by folinic acid of the peripheral blood progenitor pool after chemotherapy: its use in autografting in acute leukaemia. Br J Haematol (1990) 2.02
Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine (1992) 1.97
The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part I. Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry (2000) 1.91
The V domain of herpesvirus Ig-like receptor (HIgR) contains a major functional region in herpes simplex virus-1 entry into cells and interacts physically with the viral glycoprotein D. Proc Natl Acad Sci U S A (1998) 1.87
Cognitive and psychosocial features of childhood and juvenile MS. Neurology (2008) 1.85
Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study. Ann Oncol (2012) 1.78
Electrocautery as a factor in seroma formation following mastectomy. Am J Surg (1998) 1.75
Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype. Ann Oncol (2002) 1.74
Physiological outcomes of aerobic exercise training in hemiparetic stroke patients. Stroke (1995) 1.73
Thoracoscopic repair of H-type tracheoesophageal fistula in the newborn: a technical case report. J Pediatr Surg (2004) 1.72
Clinical phenotype associated with terminal 2q37 deletion. Clin Genet (1995) 1.63
1alpha,25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. J Biol Chem (2001) 1.62
Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J (1993) 1.59
Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. Kidney Int (1993) 1.56
Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting. Results of a prospective randomized trial. Cancer (1994) 1.55
Mononuclear cell chemoattractant activity from cultured arterial smooth muscle cells. Exp Mol Pathol (1982) 1.51
Risk stratification after myocardial infarction. A reappraisal in the era of thrombolysis. The Groupe d'Etude du Pronostic de l'Infarctus du Myocarde (GREPI) Eur Heart J (1997) 1.47
In vitro generation of dendritic cells from human blood monocytes in experimental conditions compatible for in vivo cell therapy. J Hematother Stem Cell Res (2000) 1.43
Influence of high-grade prostatic intra-epithelial neoplasia on total and percentage free serum prostatic specific antigen. BJU Int (1999) 1.42
Conservative surgery and radiotherapy in early stage breast cancer: a comparison between tumourectomy and quadrantectomy. Radiother Oncol (1998) 1.42
Combined suicide and cytokine gene therapy for peritoneal carcinomatosis. Gut (2000) 1.39
The murine homolog of human Nectin1delta serves as a species nonspecific mediator for entry of human and animal alpha herpesviruses in a pathway independent of a detectable binding to gD. Proc Natl Acad Sci U S A (2000) 1.38
Prevalence of dust mites in the homes of people with asthma living in eight different geographic areas of the United States. J Allergy Clin Immunol (1992) 1.34
Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecan. Pharmacogenomics J (2010) 1.33
Treatment of inoperable and/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase II study. J Clin Oncol (2001) 1.32
Changes of serum sICAM-1 and MMP-9 induced by rIFNbeta-1b treatment in relapsing-remitting MS. Neurology (1999) 1.31
Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma. Leukemia (2003) 1.29
Comparison of Candida-delayed hypersensitivity skin test size with lymphocyte transformation, migration inhibitory factor production and antibody titer. Int Arch Allergy Appl Immunol (1974) 1.29
Ras family genes: an interesting link between cell cycle and cancer. J Cell Physiol (2002) 1.29
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance? Ann Oncol (2012) 1.28
Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice. Ann Oncol (2007) 1.28
Kenny-Caffey syndrome in two sibs born to consanguineous parents: evidence for an autosomal recessive variant. Am J Med Genet (1992) 1.26
Prosthetic repair of a perforated Amyand's hernia: hazardous or feasible? Hernia (2007) 1.26
Anti-CD2 (sheep red blood cell receptor) monoclonal antibodies and T cell activation. I. Pairs of anti-T11.1 and T11.2 (CD2 subgroups) are strongly mitogenic for T cells in presence of 12-O-tetradecanoylphorbol 13-acetate. Eur J Immunol (1986) 1.25
Human nectin3/PRR3: a novel member of the PVR/PRR/nectin family that interacts with afadin. Gene (2000) 1.24
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. Ann Oncol (2006) 1.18
Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study. J Clin Oncol (2001) 1.17
Mapping of avirulence genes in Phytophthora infestans with amplified fragment length polymorphism markers selected by bulked segregant analysis. Genetics (2001) 1.16
The natural history of clinical operational tolerance after kidney transplantation through twenty-seven cases. Am J Transplant (2012) 1.15
Chimeric nectin1-poliovirus receptor molecules identify a nectin1 region functional in herpes simplex virus entry. J Virol (2001) 1.15
Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer. Oncogene (2006) 1.15
Infusion of allogeneic-related HLA mismatched mesenchymal stem cells for the treatment of incomplete engraftment following autologous haematopoietic stem cell transplantation. Leukemia (2007) 1.13
Cardiac complications after bone marrow transplantation. A report on a series of 63 consecutive transplantations. Cancer (1986) 1.12
Level of Flt3-ligand in plasma: a possible new bio-indicator for radiation-induced aplasia. Int J Radiat Biol (2001) 1.11
Elevation of a collagenase generated type II collagen neoepitope and proteoglycan epitopes in synovial fluid following induction of joint instability in the dog. Osteoarthritis Cartilage (2002) 1.11
[A comparative study of the feasibility and limits of ambulatory surgery in infants under and over one year of age]. Ann Chir (2004) 1.08
Antineoplastic bryostatins are multipotential stimulators of human hematopoietic progenitor cells. Proc Natl Acad Sci U S A (1987) 1.08
On the possible causes of the release of material absorbing at 260 m-mu by streptomycin treated E. coli cells (K 12 and B). J Antibiot (Tokyo) (1967) 1.08
Selected Stro-1-enriched bone marrow stromal cells display a major suppressive effect on lymphocyte proliferation. Int J Lab Hematol (2009) 1.08
Effect of disodium cromoglycate on certain passive cutaneous anaphylactic reactions. J Immunol (1969) 1.07
Prevalence of basidiomycete allergy in the USA and Europe and its relationship to allergic respiratory symptoms. Allergy (1994) 1.06
Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis. Cytokine (1992) 1.06
Efficient adenovirus-mediated gene transfer into human blood monocyte-derived macrophages. Biochem Biophys Res Commun (1993) 1.06
[Release of nucleotides and integrity of the bacterial membrane (E. coli K 12)]. Antibiotica (1966) 1.06
Cyclic AMP-responsive element binding protein in brain mitochondria. J Neurochem (1999) 1.06
Antibacterial activity of glycosylated and phosphorylated chromogranin A-derived peptide 173-194 from bovine adrenal medullary chromaffin granules. J Biol Chem (1996) 1.06
Anaemia in cancer: pathophysiology and treatment. Cancer Treat Rev (2000) 1.05
A role for the 72 kDa gelatinase (MMP-2) and its inhibitor (TIMP-2) in human parturition, premature rupture of membranes and intraamniotic infection. J Perinat Med (2001) 1.05
Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC (RASCAL) and TP53CRC collaborative studies. Ann Oncol (2005) 1.05
Adjuvant colon cancer chemotherapy: where we are and where we'll go. Cancer Treat Rev (2010) 1.05
Dysregulated biomarkers induce distinct pathways in preterm birth. BJOG (2012) 1.04
Efficacy of double intrauterine insemination in controlled ovarian hyperstimulation cycles. Fertil Steril (1999) 1.04
Disturbances of cardiac rhythm during anesthesia and surgery. JAMA (1971) 1.04
Measurement of IgG antibody and airborne antigen to control an industrial outbreak of hypersensitivity pneumonitis. J Occup Med (1983) 1.03
Comparison of murine and human nectin1 binding to herpes simplex virus glycoprotein D (gD) reveals a weak interaction of murine nectin1 to gD and a gD-dependent pathway of entry. Virology (2001) 1.03
Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers. Ann Oncol (2006) 1.03
Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic target. Cancer Treat Rev (2010) 1.02
Is it time to revise the normal range of serum uric acid levels? Eur Rev Med Pharmacol Sci (2014) 1.02
Matrix metalloproteinases-9 in preterm and term human parturition. J Matern Fetal Med (1999) 1.02
Relation between variation in copy number of ribosomal RNA encoding genes and size of harbouring chromosomes in Leishmania of subgenus Viannia. Mol Biochem Parasitol (1998) 1.02
The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part II: Tactics. Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry (2000) 1.02
A revised anchored version of the BPRS-C for childhood psychiatric disorders. J Child Adolesc Psychopharmacol (2001) 1.02
Evaluation of the deswelling period in dextran-containing medium after corneal organ culture. Cornea (1997) 1.02
Cathepsin D in the malignant progression of neoplastic diseases (review). Anticancer Res (1992) 1.01